What is Celldex Therapeutics, Inc's Market Cap?

Celldex Therapeutics, Inc's Market Cap is $2.3B, based on as-reported figures from SEC (XBRL) filings.

What is Celldex Therapeutics, Inc's Enterprise Value?

Celldex Therapeutics, Inc's Enterprise Value is $1.6B, based on as-reported figures from SEC (XBRL) filings.

What is Celldex Therapeutics, Inc's Price / Sales?

Celldex Therapeutics, Inc's Price / Sales is 14537.9×, based on as-reported figures from SEC (XBRL) filings.

What is Celldex Therapeutics, Inc's EV / Revenue?

Celldex Therapeutics, Inc's EV / Revenue is 9996.2×, based on as-reported figures from SEC (XBRL) filings.

What is Celldex Therapeutics, Inc's EV / EBITDA?

Celldex Therapeutics, Inc's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Celldex Therapeutics, Inc's Revenue (TTM)?

Celldex Therapeutics, Inc's Revenue (TTM) is $158.0K, based on as-reported figures from SEC (XBRL) filings.

What is Celldex Therapeutics, Inc's Net Income (TTM)?

Celldex Therapeutics, Inc's Net Income (TTM) is -$300.5M, based on as-reported figures from SEC (XBRL) filings.

What is Celldex Therapeutics, Inc's EBITDA?

Celldex Therapeutics, Inc's EBITDA is -$322.4M, based on as-reported figures from SEC (XBRL) filings.

What is Celldex Therapeutics, Inc's Diluted EPS (TTM)?

Celldex Therapeutics, Inc's Diluted EPS (TTM) is -3.83, based on as-reported figures from SEC (XBRL) filings.

What is Celldex Therapeutics, Inc's EBITDA Margin?

Celldex Therapeutics, Inc's EBITDA Margin is -204070.9%, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

Celldex Therapeutics, Inc

XNAS · usd

SIC 2835 · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

FIGI BBG001S7QN20

29.25▲ 0.28 (0.97%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales
EV / Revenue
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt

Trading Information

Previous Close: 28.97
Day's Range: 28.20 – 29.38
52-Week Range: 22.10 – 45.14
Volume: 879.6K
Avg Volume: 1.9M

Share Statistics

Shares Outstanding
Employees: 198
Exchange: XNAS
Listed: 1986-05-15

Share count as of July 29, 2026

Celldex Therapeutics, Inc (CLDX) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Celldex Therapeutics, Inc (CLDX)

What is Celldex Therapeutics, Inc's Market Cap?: Celldex Therapeutics, Inc's Market Cap is $2.3B, based on as-reported figures from SEC (XBRL) filings.
What is Celldex Therapeutics, Inc's Enterprise Value?: Celldex Therapeutics, Inc's Enterprise Value is $1.6B, based on as-reported figures from SEC (XBRL) filings.
What is Celldex Therapeutics, Inc's Price / Sales?: Celldex Therapeutics, Inc's Price / Sales is 14537.9×, based on as-reported figures from SEC (XBRL) filings.
What is Celldex Therapeutics, Inc's EV / Revenue?: Celldex Therapeutics, Inc's EV / Revenue is 9996.2×, based on as-reported figures from SEC (XBRL) filings.
What is Celldex Therapeutics, Inc's EV / EBITDA?: Celldex Therapeutics, Inc's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Celldex Therapeutics, Inc's Revenue (TTM)?: Celldex Therapeutics, Inc's Revenue (TTM) is $158.0K, based on as-reported figures from SEC (XBRL) filings.
What is Celldex Therapeutics, Inc's Net Income (TTM)?: Celldex Therapeutics, Inc's Net Income (TTM) is -$300.5M, based on as-reported figures from SEC (XBRL) filings.
What is Celldex Therapeutics, Inc's EBITDA?: Celldex Therapeutics, Inc's EBITDA is -$322.4M, based on as-reported figures from SEC (XBRL) filings.
What is Celldex Therapeutics, Inc's Diluted EPS (TTM)?: Celldex Therapeutics, Inc's Diluted EPS (TTM) is -3.83, based on as-reported figures from SEC (XBRL) filings.
What is Celldex Therapeutics, Inc's EBITDA Margin?: Celldex Therapeutics, Inc's EBITDA Margin is -204070.9%, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · CLDXAs-filed SEC (XBRL) data